NUE
51
3
MKC
56
3
CTAS
53
3
CL
50
2
MAR
56
2
MLM
58
-2
AXP
64
4
EQIX
60
3
AFL
41
4
GME
57
2
PNR
69
6
CI
40
2
L
51
5
COST
54
4
UNP
48
6
HRL
30
3
NTAP
54
2
PEG
50
4
BA
48
-5
NWSA
78
5
NUE
51
3
MKC
56
3
CTAS
53
3
CL
50
2
MAR
56
2
MLM
58
-2
AXP
64
4
EQIX
60
3
AFL
41
4
GME
57
2
PNR
69
6
CI
40
2
L
51
5
COST
54
4
UNP
48
6
HRL
30
3
NTAP
54
2
PEG
50
4
BA
48
-5
NWSA
78
5
Financhill
Back

Haemonetics 10K Form

Buy
54

HAE
Haemonetics

Last Price:
74.94
Seasonality Move:
4.35%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-02-08 10Q HAE/Haemonetics Quarterly
2023-11-02 10Q HAE/Haemonetics Quarterly
2023-08-08 10Q HAE/Haemonetics Quarterly
2023-02-07 10Q HAE/Haemonetics Quarterly
2022-11-08 10Q HAE/Haemonetics Quarterly
2022-08-10 10Q HAE/Haemonetics Quarterly

Receive HAE News And Ratings

See the #1 stock for the next 7 days that we like better than HAE

HAE Financial Statistics

Sales & Book Value

Annual Sales: $1.31B
Cash Flow: $-33.08M
Price / Cash Flow: 54.36
Annual Sales: $17.70
Price / Book: 4.24

Profitability

EPS (TTM): 2.23000
Net Income (TTM): $114.89M
Gross Margin: $691.55M
Return on Equity: 12.58%
Return on Assets: 5.27%

Haemonetics Earnings Forecast

Key Haemonetics Financial Ratios

  • The Gross Profit Margin over the past 33 years for HAE is 52.83%.
  • The Selling, General & Administrative Expenses for HAE have been equal to 32.98% of Gross Profit Margin.
  • The Research & Development expenses have been 4.16% of Revenue.
  • The Interest Expense is 11.07% of Operating Income.
  • The Net Earning history of HAE is 8.98% of Total Revenues.
  • Per Share Earnings over the last 34 years have been positive in 21 years.

Haemonetics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: HAE
CUSIP: 405024
Website: haemonetics.com

Debt

Debt-to-Equity Ratio: 1.35
Current Ratio: 3.76
Quick Ratio: 2.1

Price-to-Earnings

Trailing P/E Ratio: 32.74
Forward P/E Ratio: 14.01

HAE Technical Analysis vs Fundamental Analysis

Buy
54
Haemonetics (HAE) is a Buy

Is Haemonetics a Buy or a Sell?

  • Haemonetics stock is rated a Buy
    The current Haemonetics [HAE] share price is $74.98. The Score for HAE is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.